ReAx Therapeutics
Biotechnology company developing a next-generation chemoproteomics platform to identify and target novel hotspots across the proteome in disease-relevant contexts.
Investors
1
Categories
biotech, chemoproteomics, drug-discovery, proteomics
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |